Invesco
IRMD icon

Invesco’s iRadimed IRMD Stock Holding History

Invesco’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$707K Sell
7,395
-11,267
-60% -$1.03M ﹤0.01% 3095
2026
Q1 		$1.8M Sell
18,662
-16,469
-47% -$1.65M ﹤0.01% 2591
2025
Q4 		$3.42M Buy
35,131
+29,010
+474% +$2.49M ﹤0.01% 2406
2025
Q3 		$436K Buy
6,121
+2,173
+55% +$145K ﹤0.01% 3284
2025
Q2 		$236K Sell
3,948
-564
-13% -$30.9K ﹤0.01% 3469
2025
Q1 		$237K Sell
4,512
-108
-2% -$6.07K ﹤0.01% 3442
2024
Q4 		$254K Buy
+4,620
New +$243K ﹤0.01% 3462
2024
Q3 		– Sell
-7,081
Closed -$311K – 3816
2024
Q2 		$311K Buy
+7,081
New +$301K ﹤0.01% 3487
2024
Q1 		– Sell
-8,371
Closed -$397K – 3900
2023
Q4 		$397K Buy
8,371
+1,450
+21% +$61K ﹤0.01% 3329
2023
Q3 		$307K Sell
6,921
-8
-0.1% -$372 ﹤0.01% 3448
2023
Q2 		$331K Buy
+6,929
New +$312K ﹤0.01% 3455
2022
Q2 		– Sell
-33,556
Closed -$1.5M – 4088
2022
Q1 		$1.5M Sell
33,556
-6,782
-17% -$314K ﹤0.01% 2893
2021
Q4 		$1.86M Buy
+40,338
New +$1.63M ﹤0.01% 2817
2020
Q3 		– Sell
-40,522
Closed -$941K – 3655
2020
Q2 		$941K Buy
40,522
+29,628
+272% +$636K ﹤0.01% 2825
2020
Q1 		$232K Sell
10,894
-36,696
-77% -$874K ﹤0.01% 3351
2019
Q4 		$1.11M Sell
47,590
-779
-2% -$18.2K ﹤0.01% 2944
2019
Q3 		$1.02M Buy
+48,369
New +$987K ﹤0.01% 2997
2019
Q2 		– Sell
-10,800
Closed -$303K – 3743
2019
Q1 		$303K Sell
10,800
-2,948
-21% -$77.2K ﹤0.01% 3484
2018
Q4 		$336K Buy
13,748
+15
+0.1% +$403 ﹤0.01% 3429
2018
Q3 		$510K Buy
+13,733
New +$371K ﹤0.01% 3424
2016
Q1 		– Sell
-77,805
Closed -$2.18M – 3724
2015
Q4 		$2.18M Sell
77,805
-606
-0.8% -$17.1K ﹤0.01% 2468
2015
Q3 		$1.91M Buy
78,411
+78,172
+32,708% +$1.87M ﹤0.01% 2536
2015
Q2 		$6K Buy
+239
New +$4.37K ﹤0.01% 4120

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's IRMD Position: Q2 2026 in Review

Invesco reduced its iRadimed (IRMD) stake by 60% in Q2 2026, selling an estimated $1.03M and leaving 7,395 shares worth $707K. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Invesco first reported a position in IRMD in Q2 2015 and has held it in 23 quarters since. The position peaked at $3.42M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Invesco held 7,395 shares of iRadimed worth $707K as of Q2 2026.
  • Invesco sold 11,267 iRadimed shares in Q2 2026, an estimated $1.03M.
  • iRadimed made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3095 holding.
  • Invesco first reported a position in iRadimed in Q2 2015 and has held it in 23 quarters since.
  • Invesco's iRadimed position peaked at $3.42M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.